Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers

Decisions from Aetna, Cigna and UnitedHealthcare followed the latest update to the American Society of Clinical Oncology (ASCO) guidelines recommending MammaPrint® Breast Cancer Risk of Recurrence Test for certain breast cancer patients Majority of ... Diagnostics, Personalized Medicine, Oncology, Reimbursement Agendia, MammaPrint
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news